Abstract:AACR Centennial Conference: Translational Cancer Medicine-- July 20-23, 2008; Monterey, CA B16 This study is designed to identify and verify heat shock protein 90 (HSP90) pharmacodynamic RNA biomarkers and to develop a single multiplex panel to monitor them in a clinical setting. HSP90 is a ubiquitously expressed molecular chaperone which is involved in multiple cellular functions, such as signal transduction and protein folding. Together with other co-chaperones, HSP90 participates in many key processes in oncogenesis including growth factor independence, stabilization of mutant proteins, angiogenesis, and metastasis, by regulating the maturation and stability of its client proteins. Among HSP90 clients are Her2, v-Src, Bcr-Abl, p53 mutant, VEGF, NOS, MMP2, AKT, and steroid receptors. Multiple cancer drugs have targeted HSP90 to inhibit its activity in cancerous cells, including geldanamycin and its derivatives, and ridicicol. In pre-clinical and clinical development, HSP70, CDK4 and other proteins have been used as single biomarkers to monitor drug activity and response. We have developed a multivariate biomarker development system based on our proprietary multiplex PCR technology, which utilizes Beckman Coulter’s GeXP CEQ platform. Utilizing this process we have identified a set of RNA biomarkers whose in vitro expression in a inhibitor sensitive cell line is significantly altered by the HSP90 inhibitors 17-N-Allylamino-17-demethoxygeldanamycin (17-AAG) and Ridicicol. Their expression changes in a dose and time dependent manner and the changes are not compound specific, suggesting that this panel may have broad utility for therapeutics that target the HSP90 pathway. We have produced a single multiplex assay that is capable of monitoring all of these targets in a single reaction. We have now expanded this study to include additional sensitive and insensitive cell lines for verification, as well as carried out IC50 assays to analyze for correlation to our gene expression results. Additionally, we have designed and carried out experiments to determine the correlation between data obtained in vitro and the drug response seen in vivo . We have successfully verified these biomarkers and correlated their activity to responses measured in IC50 assays. We now plan to begin validation of in vivo responses with human clinical samples.

Design of A Flexible Cell-Based Assay for the Evaluation of Heat Shock Protein 70 Expression Modulators

Assay design and development strategies for finding Hsp90 inhibitors and their role in human diseases

Targeting Allosteric Control Mechanisms in Heat Shock Protein 70 (Hsp70).

High-Throughput Screening Fluorescence Polarization Assay for Tumor-Specific Hsp90

Targeting HSP70: The second potentially druggable heat shock protein and molecular chaperone?

Verification of a Multivariate Pharmacodynamic Biomarker Assay for HSP90 Inhibitors

A Novel Method To Assay Molecular Chaperone Activity Of Hsp70: Evaluation Of Drug Resistance In Cancer Treatment

Heat-shock protein 70: molecular supertool?

Combined In-Solution Fragment Screening and Crystallographic Binding-Mode Analysis with a Two-Domain Hsp70 Construct

Sensitive and rapid determination of heat shock protein 70 using lateral flow immunostrips and upconversion nanoparticle fluorescence probes

High-throughput screen for Escherichia coli heat shock protein 70 (Hsp70/DnaK): ATPase assay in low volume by exploiting energy transfer

Endogenous epitope tagging of heat shock protein 70 isoform Hsc70 using CRISPR/Cas9

Hsp70 Protein Complexes as Drug Targets

Heat Shock Protein 70 (HSP70) Induction: Chaperonotherapy for Neuroprotection after Brain Injury

Structural Basis for the Inhibition of HSP70 and DnaK Chaperones by Small-Molecule Targeting of a C-Terminal Allosteric Pocket

Facilitating Akt Clearance via Manipulation of Hsp70 Activity and Levels

Identification of novel small molecule chaperone activators for neurodegenerative disease treatment

Sensitive detection of HSP70 using a current-amplified biosensor based on antibody-loaded PS-AuNPs@Cys/Au modified ITO chip

Localization and Expression of Heat Shock Protein 70 with Rat Myocardial Cell Damage Induced by Heat Stress in Vitro and in Vivo

Design, synthesis, and biological evaluation of novel HSP27 inhibitors to sensitize lung cancer cells to clinically available anticancer agents

An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitors